| Literature DB >> 33036315 |
Mayara Castro de Morais1, Jucieudo Virgulino de Souza1, Carlos da Silva Maia Bezerra Filho1, Silvio Santana Dolabella2, Damião Pergentino de Sousa1.
Abstract
Trypanosomiases are diseases caused by parasitic protozoan trypanosomes of the genus Trypanosoma. In humans, this includes Chagas disease and African trypanosomiasis. There are few therapeutic options, and there is low efficacy to clinical treatment. Therefore, the search for new drugs for the trypanosomiasis is urgent. This review describes studies of the trypanocidal properties of essential oils, an important group of natural products widely found in several tropical countries. Seventy-seven plants were selected from literature for the trypanocidal activity of their essential oils. The main chemical constituents and mechanisms of action are also discussed. In vitro and in vivo experimental data show the therapeutic potential of these natural products for the treatment of infections caused by species of Trypanosoma.Entities:
Keywords: African trypanosomiasis; Chagas disease; Trypanosoma; essential oils; natural product; neglected disease; protozoan; terpene; trypanosomiasis
Mesh:
Substances:
Year: 2020 PMID: 33036315 PMCID: PMC7583723 DOI: 10.3390/molecules25194568
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Worldwide distribution of the main species causing human trypanosomiasis.
Essential oils with trypanocidal activity against T. cruzi.
| Plant | Experimental Models | Dose/ | Major Constituent(s) |
|---|---|---|---|
| In vitro (Microdilutions/Culture) | 145.5 µg/mL | chamazulene | |
| In vivo (Orogastric tube) | 100 mg/kg | Citral | |
| In vitro (Microdilutions/Culture) | 67.18 μg/mL | 1,8-cineole | |
| In vitro (Microdilutions/Culture) | 89.7 µg/mL | δ-cadinene | |
| In vitro (Microdilutions/Culture) | 27.2 µg/mL | bicyclogermacrene | |
| In vitro (Microdilutions/Culture) | 31.9 µg/mL | bicyclogermacrene | |
| In vitro (Microdilutions/Culture) | 1 µg/mL | ||
| In vitro (Microdilutions/Culture) | 100 µg/mL | 1,8-cineole | |
| In vitro (Microdilutions/Culture) | 0.46 μg/mL | linalool, 1-epi-cubenol | |
| In vitro (Microdilutions/Culture) | 21.3 μg/mL | terpinolene | |
| In vitro (Microdilutions/Culture) | 209.3 µg/mL | monoterpene hydrocarbons, sesquiterpene, hydrocarbons, α-pinene, | |
| In vitro (Microdilutions/Culture) | 5.05 μg/mL | ( | |
| In vitro | 15.5 µg/mL | citral | |
| In vitro (Microdilutions/Culture) | 6.2 μM | geranial | |
| In vitro (Microdilutions/Culture) | 0.46 μg/mL | 4-heptanol | |
| In vitro (Microdilutions/Culture) | 29 ± 4.5 µg/mL (Epimastigote) | δ-cadinene | |
| In vitro (Microdilutions/Culture) | 0.3 μg/mL | β-selinene | |
| In vitro (Microdilutions/Culture) | 0.029 μg/mL | germacrene D | |
| In vitro (Microdilutions/Culture) | 56.1 ± 17 µg/mL (Epimastigote) | ||
| In vitro (Microdilutions/Culture) | 42.13 ± 9.34 µg/mL (Epimastigote) | xanthoxylin | |
| In vitro (Microdilutions/Culture) | 44.5 µg/mL | terpinolene | |
| In vitro (Microdilutions/Culture) | 201.94 μg/mL | ( | |
| In vitro (Microdilutions/Culture) | 37.6 ± 5 µg/mL (Epimastigote) | thymol | |
| In vitro (Microdilutions/Culture) | 10.3 µg/mL | thymol | |
| In vitro (Microdilutions/Culture) | 11.3 µg/mL | ( | |
| In vitro (Microdilutions/Culture) | 5.5 µg/mL | citral | |
| In vitro (Microdilutions/Culture) | 24.3 µg/mL | citral | |
| In vitro (Microdilutions/Culture) | 32.8 µg/mL | citral | |
| In vitro (Microdilutions/Culture) | 50.6 µg/mL | ||
| In vitro (Microdilutions/Culture) | 9.9 µg/mL | carvacrol | |
| In vitro (Microdilutions/Culture) | 102 µg/mL | linalool | |
| In vitro (Microdilutions/Culture) | 115 µg/mL | 3-cycle-hexen-1-ol | |
| In vitro (Microdilutions/Culture) | >90 μg/mL | carvacrol | |
| In vitro (Microdilutions/Culture) | 2.2 µg/mL | lavandulyl acetate | |
| In vitro (Microdilutions/Culture) | 8.0 µg/mL | camphene | |
| In vitro (Microdilutions/Culture) | 45.5 µg/mL | sabinene, eucalyptol | |
| In vitro (Microdilutions/Culture) | 28.55 μg/mL | spathulenol | |
| In vitro (Microdilutions/Culture) | 209.3 µg/mL | β-myrcene | |
| In vitro (Microdilutions/Culture) | 5, 10, 15, and 20 μg/mL | kaurenoic acid | |
| In vitro (Microdilutions/Culture) | 57.5 µg/mL | eugenol | |
| In vitro (Microdilutions/Culture) | 100.6 ± 38 µg/mL (Epimastigote) | octanoic acid, | |
| In vitro (Microdilutions/Culture) | 38 µg/mL | Thymol | |
| In vitro (Microdilutions/Culture) | 12.7 μg/mL | Germacrene bicyclogermacrene | |
| In vitro (Microdilutions/Culture) | 11.9 μg/mL | ( | |
| In vitro (Microdilutions/Culture) | 155.8 µg/mL | terpinyl acetate |
Essential oils with trypanocidal activity against T. brucei.
| Plant | Experimental Models | Dose/ | Major Constituent(s) |
|---|---|---|---|
| In vitro (Microdilutions/Culture) | 1.5 µL/mL | β-pinene | |
| In vitro (Microtiter/Culture) | 7.65 µg/mL | sabinene | |
| In vitro (Microtiter/Culture) | 15.21 ± 0.97 µg/mL | germacrene B | |
| In vitro (Microdilutions/Culture) | 5.0 ± 0.8 µg/mL | limonene | |
| In vitro (Microdilutions/Culture) |
33.5 µg/mL with the essential oil, |
spathulenol | |
| In vitro (Microdilutions/Culture) | 3.17 ± 0.72 ng/mL | α-zingiberene | |
| In vitro (Microdilutions/Culture) | 2.51 ± 1.08 ng/mL | 8,9-Dehydro-9-formyl cycloisolongifolene | |
| In vitro (Microdilutions/Culture) | 3.2 μg/mL | citral | |
| In vitro (Microdilutions/Culture) | 0.25 µg/ml | ||
| In vitro (Microdilutions/Culture) | 5.71 µg/mL | β-citronellal | |
| In vitro (Microdilutions/Culture) | 2.10 µg/mL | piperitone | |
| In vitro (Microdilutions/Culture) | 2.7 ± 0.6 μg/mL | myristicin | |
| In vitro (Microdilutions/Culture) | 4.0 ± 1.6 μg/mL | α-phellandrene | |
| In vitro (Microdilutions/Culture) | 10.50 µg/mL | silphiperfol-6-ene | |
| In vitro (Microdilutions/Culture) | 33.5 µg/mL | spathulenol | |
| In vitro (Microdilutions/Culture) | 11.20 μg/mL | spathulenol | |
| In vitro (Microdilutions/Culture) | 42.30 µg/mL | ledol | |
| In vitro (Microdilutions/Culture) | 10.7 ± 4 µg/mL | myristicin | |
| In vitro (Microdilutions/Culture) | 0.9 μg/mL | monoterpene hydrocarbons | |
| In vitro (Microdilutions/Culture) | 50.52 µg/mL | δ-cadinene, camphene | |
| In vitro (Microdilutions/Culture) | 20.9 µg/mL | ||
| In vitro (Microdilutions/Culture) | 5.7 μg/mL | oxygen-containing monoterpenes | |
| In vitro (Microdilutions/Culture) | 15.41 µg/mL | caryophyllene oxide | |
| In vitro (Microdilutions/Culture) | 2.67 ± 1.12 ng/mL | Citronellal | |
| In vitro (Microdilutions/Culture) | 0.3 µg/mL | rotundifolone | |
| In vitro (Microdilutions/Culture) | 5.03 µg/mL | benzyl isothiocyanate | |
| In vitro (Microdilutions/Culture) | 1.66 µg/mL | ||
| In vitro (Microdilutions/Culture) | >90 μg / mL | carvacrol | |
| In vitro (Microdilutions/Culture) | 8.0 µg/mL | lavandulyl acetate | |
| In vitro (Microdilutions/Culture) | 8.1 µg/mL | camphene | |
| In vitro (Microdilutions/Culture) | 4.3 ± 0.7 µg/mL | sabinene | |
| In vitro (Microdilutions/Culture) | 1.9–4.0 µg/mL | isofuranodiene | |
| In vitro (Microdilutions/Culture) | 13.5 μg/mL | palmitic acid | |
| In vitro (Microdilutions/Culture) | 3.10 ± 0.08 ng/mL | α-zingiberene |
Essential oils with trypanocidal activity against T. evansi.
| Plant | Experimental Models | Dose/ | Major Constituent(s) |
|---|---|---|---|
| In vivo | 1.5 mL/kg | α-pinene | |
| In vitro | 0.5, 1.0 and 2.0% of the tested oil concentration | 1-nitro-2-phenylethane | |
| In vitro | 0.5% | ||
| In vivo | 0.5, 1.0 and 2.0% | citral | |
| In vivo | 0.5, 1.0 and 2.0% | carvacrol | |
| In vivo | 1 mL/kg | terpinen-4-ol | |
| In vitro | 0.5% | mono and sesquiterpenes |
Figure 2Main mechanisms of the trypanocidal action of essential oils. Source: Adapted from Grivicich, I.; Regner, A.; d. Rocha, A.B., 2007 [72].